EVE, recently refreshed their brand to target broader audience. Sells raw honey probiotics (large market in Asia), Meluka Honeys, Tea tree and essential oils.
Milestone, 1) Completing $9.3m placement with two strategic investors Everhoney Biotech Australia Pty Ltdand Hong Kong Jusheng Bolang Technology Co., Limited.
2) The product launch in China to Hunan Yandi Bioengineering (Yandi), a leading green life andhealth care distributor and one of China’s largest direct selling organisations with over onemillion members in its distribution network.
3) The Company launched its first branded tea tree oil product, with the maiden sale to Yandi forthe Chinese market highlighting the value of the Chinese market to the Company’s growth.
4) The launch of the Company’s unique bio‐fermented honey and lemon probiotic concentrate targeting the growing gut health market segment. The response to the new product has been beyond the Company’s expectations and we look forward to expanding out the probiotic concentrate line.
Capital raise in Jan 2020 with the funding used to target key markets: China, US, Aus and Japan.
